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Edited by Maurice MontalAbstract Agelenin, isolated from the Agelenidae spider Age-
lena opulenta, is a peptide composed of 35 amino acids. We
determined the three-dimensional structure of agelenin using
two-dimensional NMR spectroscopy. The structure is composed
of a short antiparallel b-sheet and four b-turns, which are stabi-
lized by three disulﬁde bonds. Agelenin has characteristic resi-
dues, Phe9, Ser28 and Arg33, which are arranged similarly to
the pharmacophore of the insect channel inhibitor, x-atraco-
toxin-Hv1a. These observations suggest that agelenin and x-atr-
acotoxin-Hv1a bind to insect calcium channels in a similar
manner. We also suggest that another mode of action may oper-
ate in the channel inhibition by x-agatoxin-IVA and x-atraco-
toxin-Hv2a.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Insect calcium channel1. Introduction
Many toxic peptides isolated from venomous animals, e.g.,
insects, scorpions, snakes, spiders and marine cone snails, are
known to inhibit voltage-sensitive ion channels with high selec-
tivity of channel subtypes [1,2]. These peptides have proven to
be a valuable pharmacological tool for exploring structure and
function of each channel subtype [1,2]. The three-dimensional
structures of these peptides have provided insights into the
mechanism by which these peptides inhibit their target chan-
nels [3].Abbreviations: ICK, inhibitor cystine knot; NMR, nuclear magnetic
resonance; DQF-COSY, double-quantum-ﬁltered correlation spectros-
copy; TOCSY, total correlation spectroscopy; NOESY, nuclear
Overhauser eﬀect spectroscopy; H–D exchange, hydrogen–deuterium
exchange; PD50, 50% paralytic dose; RMSD, root-mean-square
deviation; x-Aga-IVA, x-agatoxin-IVA; x-ACTX-Hv1a, x-atraco-
toxin-Hv1a; x-ACTX-Hv2a, x-atracotoxin-Hv2a
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doi:10.1016/j.febslet.2007.06.077x-Agatoxin-IVA (x-Aga-IVA), isolated from the American
funnel-web spider, Agelenopsis aperta, is a well-characterized
peptide which is an inhibitor of both insect and mammalian
Cav2 calcium channels [4–6]. x-Atracotoxin-Hv1a (x-ACTX-
Hv1a) and x-atracotoxin-Hv2a (x-ACTX-Hv2a), isolated
from the Australian funnel-web spider, Hadronyche versuta,
display high species selectivity towards insect calcium chan-
nels, but are inactive toward mammalian calcium channels
[7–10]. Despite the diﬀerence in their targets, these peptides
share a very characteristic disulﬁde-bonding pattern desig-
nated as the inhibitor cystine knot (ICK) motif [11].
Agelenin, composed of 35 amino acids with three disulﬁde
bonds, was isolated from the venom of the Agelenidae spi-
der, Agelena opulenta [12–14]. It was suggested that agelenin
irreversibly inhibits invertebrate presynaptic calcium channels
[14], but its mode of action was unknown. With the excep-
tion of the ICK motif, the sequence homology between age-
lenin and other calcium channel inhibitors is very low. The
aim of this study is to elucidate the mode of inhibition of
agelenin based on its structure, and to provide new structural
knowledge on calcium channel inhibitors and species selectiv-
ity. For this purpose, we ﬁrst determined the solution struc-
ture of agelenin using two-dimensional nuclear magnetic
resonance (NMR) spectroscopy. The structure of agelenin
thus elucidated contains a short antiparallel b-sheet con-
nected by three disulﬁde bonds, similar to the ICK toxins
including the calcium channel inhibitors. Biological assays
indicated that agelenin is toxic to insects but does not inhibit
mammalian calcium channels. In addition to the biological
activity, structural similarity to x-ACTX-Hv1a suggests that
agelenin functions in a similar way. The three key amino acid
residues in agelenin, Phe9, Ser28 and Arg33, corresponding
to Pro10, Asn27 and Arg35 in the pharmacophore of x-
ACTX-Hv1a, are considered essential for the inhibition
activity.2. Materials and methods
2.1. Materials
Agelenin and x-Aga-IVA were purchased from the Peptide Institute
(Osaka, Japan). A chimeric analogue, which is agelenin plus the C-ter-
minal tail of x-Aga-IVA (residues 38–48), was chemically synthesized
and provided by the Peptide Institute (Osaka, Japan).blished by Elsevier B.V. All rights reserved.
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Agelenin was dissolved in 90% H2O/10% D2O and 50 lM NaN3.
The pH was adjusted to 4.5 in order to detect amide proton signals.
The ﬁnal concentration was 4.1 mM.
Structural restraints including NOEs, 3JNH–Ha coupling constants
and hydrogen bonds were measured as previously described [15].
Brieﬂy, 2D double-quantum-ﬁltered correlation spectroscopy (DQF-
COSY) [16], nuclear Overhauser eﬀect spectroscopy (NOESY)
[17,18] and total correlation spectroscopy (TOCSY) [19] experiments
were performed on a Bruker AVANCE-750 spectrometer at 298 K.
NOESY spectra were acquired with mixing times of 50 and 200 ms.
The TOCSY spectrum was measured with a mixing time of 71 ms.
The DQF-COSY spectrum was recorded with 512 (t1) · 8 K (t2) data-
points, enabling us to measure the 3JNH–Ha coupling constants with
high accuracy. A hydrogen–deuterium (H–D) exchange experiment
was conducted in order to identify hydrogen bonds; amide protons
that remained detectable for 7.5 h after the peptide was dissolved in
D2O were interpreted as hydrogen-bond donors. Structure calculations
were performed using the X-PLOR-NIH 2.9.1 program [20] as de-
scribed previously [15]. The 20 lowest-energy structures were selected
and analyzed, and the structures were assessed using AQUA3.2 and
PROCHECK-NMR3.4 [21]. The secondary structures were deﬁned
using the MOLMOL2k.1 program [22,23].2.3. Insect toxicity assays
Insect toxicity was tested using a solution of the peptides, dissolved
in an insect saline, pH 7.5 [24]. The peptides were injected into a 200–
300 mg cricket (Gryllus bimaculatus) between the second and third legs.
The dose that paralyzed 50% of the crickets at 1 h postinjection (PD50
value) was calculated using the PRISM software.2.4. Electrophysiological experiments using mammalian calcium
channels
Calcium channel currents were recorded from the human embryonic
kidney (HEK) cells that stably expressed a12.1, a2d-1 and b1 subunits
of rabbit HVA calcium channels. HEK cells were seeded onto glass
cover slips. Currents from HEK cells were recorded at room tempera-
ture with the whole-cell patch-clamp technique using the EPC-9 patch-
clamp ampliﬁer (HEKA Electronik, Lambrecht, Germany) as de-
scribed previously [25]. Stimulation and data acquisition were per-
formed using the PULSE program (version 7.5, HEKA Elektronik).
Patch pipettes were made from borosilicate glass capillaries (1.5 mm
outer diameter; Hilgenberg, Malsfeld, Germany) using a model P-87
Flaming-Brown micropipette puller (Sutter Instrument Co., San Ra-
fael, CA). The series resistance was electronically compensated to
>50% and both the leakage and the remaining capacitance were sub-
tracted.
For recordings of the whole-cell currents, the pipette solution con-
tained (in mM): CsOH 95, aspartic acid 95, CsCl 40, MgCl2 4, EGTA
5, Na2ATP 2, creatine-phosphate 8 and HEPES 5; adjusted to pH 7.3
with CsOH. The barium solution contained (in mM): BaCl2 3, TEA-Cl
148, glucose 10 and HEPES 10; adjusted to pH 7.4 with TEA-OH.
Peptides were dissolved in the 3 mM barium external solution with
cytochrome C at a concentration of 0.1 mg/mL. Rapid application of
drugs and exchange of the external solutions were performed by the
modiﬁed Y-tube method as described previously [25].Fig. 1. Summary of agelenin NMR data. Sequential NOEs, classiﬁed
as very weak, weak, medium and strong, are represented by the
thickness of bars. Filled circles indicate backbone amide protons that
form hydrogen bonds.3JNHCa coupling constants are indicated by ›
(>8 Hz) and ﬂ (<5.5 Hz). The secondary structures are denoted by bars
(turns) and arrows (b-sheets).3. Results
3.1. NMR analysis and structure calculation
Proton resonance assignments were achieved using the stan-
dard strategy [26]. A total of 521 NOE-based distance re-
straints (175 intra-residue, 158 sequential, 56 medium-range
and 132 long-range restraints) were derived from the NOESY
spectrum with a mixing time of 200 ms. Five hydrogen bonds
were identiﬁed by the hydrogen–deuterium exchange (H–D ex-
change) experiment: Arg8(NH)-Pro5(CO), Leu22(NH)-Cy-
s19(CO), Lys25(NH)-Arg33(CO), Arg33(NH)-Lys25(CO)
and Cys34(NH)-Arg8(CO). These hydrogen-bonding interac-tions were conﬁrmed by relevant NOEs. They are involved
in b-sheet and type II turns in the NMR structures. The
3JNH–Ha coupling constants were converted into / angle re-
straints with the range160 to80 for the 3JNH–Ha couplings
over 8.0 Hz, and 90 to 40 for the 3JNH–Ha couplings less
than 5.5 Hz (Fig. 1).
The solution structure of agelenin was determined by the dis-
tance restraints and the 20 dihedral angle restraints mentioned
above, in addition to the disulﬁde-bonding restraints (Cys3-
Cys19, Cys10-Cys24 and Cys18-Cys34) experimentally deter-
mined by Inui et al. [14]. Structural statistics for the ﬁnal 20
structures are summarized in Table 1. The structures are con-
sistent with the experimental restraints derived from the NMR
data; there are no NOE distance violations greater than 0.4 A˚,
and no angle violations greater than 5.0. The 20 structures
converged well, with a root-mean-square deviation (RMSD)
of 0.74 A˚ for backbone atoms and 1.35 A˚ for all heavy atoms.
The /–w backbone dihedral angles are deﬁned well in terms of
the Ramachandran plot statistics. Most of the dihedral angles
lie in the most favored or additional allowed regions, and only
5.7% of the dihedral angles are found in the generously al-
lowed region. No residues were found in the disallowed region.
The coordinates for the ensemble of the ﬁnal 20 structures
have been deposited in the RCSB Protein Data Bank, acces-
sion code 2E2S.3.2. Solution structure of agelenin
Fig. 2A shows a stereoview of the 20 agelenin structures
superimposed using the backbone heavy atoms. The structure
consists of a short antiparallel b-sheet (Cys24-Glu26 and
Ser32-Cys34) and four b-turns, which comprise the compact
core structure, connected by three disulﬁde bonds (Fig. 2B).
Among the four turns in the structure, turn 1 (Pro5-Arg8)
and turn 3 (Cys19-Leu22) are classiﬁed as type II turns
[27,28]. Although hydrogen bonds were not detected for turns
2 (Asn11-Ser14) and 4 (Ser28-Asp31) by the H–D exchange
experiment, the turn structures converged well with a RMSD
of <0.2 A˚. Turns 2 and 4 include Leu and Ile, respectively,
at the i + 2 position; since Ile and Leu at these positions are
generally unfavorable or disallowed for type I and II turns
[27,28], turns 2 and 4 cannot adopt these conformations.
Fig. 2. (A) Stereoview of the 20 lowest-energy structures of agelenin
superimposed with the lowest-RMSD structures using backbone heavy
atoms in the well-deﬁned region (residues 4–34). (B) Ribbon repre-
sentation of the lowest-energy structure of agelenin. Disulﬁde bonds
are shown in yellow. The molecules were visualized using MOLMOL
[23].
Table 1
Structural statistics for the 20 lowest-energy structures
Ramachandran analysis (residues 2–34)a
Residues in most favored regions (%) 68.4
Residues in additional allowed regions (%) 25.9
Residues in generously allowed regions (%) 5.7
Residues in disallowed regions (%) 0.0
RMSD between 20 conformers (residues 4–34)
Backbone (A˚) (N,Ca,C,O) 0.74
All heavy atoms (A˚) 1.35
Distance restraints
Intra-residue (ji  jj = 0) 175
Sequential (ji  jj = 1) 158
Medium-range (2 6 ji  jj 6 4) 56
Long-range (ji  jj > 4) 132
Total 521
Deviations from idealized covalent geometryb
Bonds (A˚) 0.0051 (±0.0003)
Angles () 0.595 (±0.036)
Impropers () 0.450 (±0.043)
Total energies (kcal/mol) 4.305 (±2.5)
aPROCHECK-NMR was used to calculate these values.
bAll statistics are given as means ± S.D [20].
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The disulﬁde core structure of agelenin resembles those of
the ICK toxins, in particular, x-Aga-IVA [5] and x-ACTX-
Hv1a [7] (Fig. 3). First, we focused on the comparison withx-Aga-IVA because there is a prominent diﬀerence between
agelenin and x-Aga-IVA in the absence or presence of an
unstructured C-terminal hydrophobic tail. A C-terminal trun-
cated analogue of x-Aga-IVA (residues 1–40) was virtually de-
void of blocking activity on mammalian Cav2.1 channel
current at a relatively high concentration, 10 lM, while the
wild-type x-Aga-IVA blocked the same channel at 10 nM
[5]. The C-terminal tail of x-Aga-IVA is, therefore, believed
to be essential for the channel blocking activity. To assess
the role of the hydrophobic C-terminal tail, a chimeric agelenin
analogue was prepared, where the C-terminal tail (residues 38–
48; PRLIMEGLGLA) of x-Aga-IVA was connected to the C-
terminus of agelenin. The CD spectrum of the chimeric ana-
logue was identical to that of the wild-type agelenin, indicating
the similarity in backbone folds of these peptides (see Support-
ing Information).3.4. Biological activity of agelenin and its chimeric analogue
Insecticidal toxicity of agelenin and its chimeric analogue
was assessed using crickets. Injection of agelenin into crickets
induced instantaneous paralysis (immobilization and contrac-
tion) (PD50 = 291 ± 104 pmol/g). The paralysis was reversible,
i.e., aﬀected crickets recovered in 2–3 h at a low concentration
(220 pmol/g) of the peptide. The injection of the chimeric
analogue paralyzed crickets with a similar potency to agelenin
(PD50 = 607 ± 61 pmol/g) (Supporting Information).
To evaluate activity against mammalian calcium channels,
the eﬀects of agelenin and the chimeric analogue on whole-cell
barium currents were recorded from HEK cells expressing rab-
bit Cav2.1 calcium channel. Neither agelenin nor the chimeric
analogue showed any eﬀect on barium currents up to 1 lM
(Fig. 4). Furthermore, the chimeric analogue did not compete
with x-Aga-IVA for binding of the Cav2.1 channel (data not
shown). We tested other mammalian calcium channels,
Cav2.2 and Cav2.3, but agelenin and the chimeric analogue
did not interact with them (data not shown).4. Discussion
The amino acid sequences of agelenin, x-ACTX-Hv1a, x-
ACTX-Hv2a and x-Aga-IVA are shown aligned based on
the positions of the cysteine residues (Fig. 3A) since these tox-
ins share the same ICK motif. This motif consists of three
disulﬁde bonds with the same bonding pattern; the fourth
disulﬁde bond in x-Aga-IVA is considered to be independent
of the ICK motif. Although x-Aga-IVA inhibits both insect
and mammalian calcium channels, x-ACTX-Hv1a and x-
ACTX-Hv2a are known to inhibit only insect calcium chan-
nels. The solution structures of these toxic peptides including
agelenin have been determined, and except for the ICK motif,
few obvious sequential similarities that would have an impact
on activity are evident. Figs. 2B and 3B show the overall folds
of these calcium channel inhibitors. These peptides commonly
possess a compact, disulﬁde core structure composed of two
antiparallel b-strands and three disulﬁde bonds. A signiﬁcant
structural diﬀerence among these peptides is that x-ACTX-
Hv2a and x-Aga-IVA possess disordered C-terminal tails but
agelenin and x-ACTX-Hv1a do not.
Biological assays showed that wild-type agelenin targets only
insects. To test the target speciﬁcity, an agelenin analogue was
Fig. 3. Comparison of agelenin and calcium channel inhibitor structures. (A) Sequence alignments of agelenin and calcium channel inhibitors
according to their cysteine positions. The red arrowhead marks the position of the residues in x-ACTX-Hv1a critical for interaction with insect
calcium channels. The disulﬁde bonding arrangement is shown in green. (B) Backbone structures of calcium channel inhibitors (Protein Data Bank
accession code: x-ACTX-Hv1a, 1AXH; x-ACTX-Hv2a, 1G9P and x-Aga-IVA, 1OAW). The disulﬁde bonds are shown in yellow.
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to agelenin. Although the overall structure of the chimeric ana-
logue was similar to that of x-Aga-IVA, the C-terminal tail
added to agelenin did not alter the speciﬁcity of the toxic activ-
ity (Fig. 4). According to a previous study with x-Aga-IVA,
which shows that the C-terminal tail plays a crucial role in
the blocking action on the mammalian Cav2.1 channel, these
results suggest that both the disulﬁde core region and the C-
terminal tail are necessary for recognition of the mammalian
Cav2.1 channel. However, the activity of the disulﬁde core re-
gion above has not been examined and thus remains unclear
[5].
In contrast to x-Aga-IVA, x-ACTX-Hv1a lacks such a
hydrophobic C-terminal tail and targets only insect calcium
channels [7–9]. Interestingly, x-ACTX-Hv2a loses its channel
inhibition activity when the C-terminal tail is truncated even
though this toxin also targets only insect calcium channels
[10]. Therefore, there must be at least two diﬀerent modes of
action among insect-speciﬁc toxins depending on their struc-
tures.
Fig. 5 shows a comparison of the structures between agele-
nin and x-ACTX-Hv1a. Alanine scan mutagenesis revealed
that Pro10, Asn27 and Arg35 of x-ACTX-Hv1a were critical
for insecticidal activity, therefore these residues were reported
to be the key components of the toxin pharmacophore [8,9]. Itwas proposed that Pro10 and Arg35 confer speciﬁc binding to
the insect calcium channel on x-ACTX-Hv1a by hydrophobic
and electrostatic interactions, respectively, and Asn27 most
likely donates a hydrogen bond to an acceptor on the channel
[8]. Agelenin also has a hydrophobic residue (Phe9), a posi-
tively charged residue (Arg33), and a hydrogen-bonding donor
(Ser28) exposed at similar locations as Pro10, Arg35 and
Asn27 in x-ACTX-Hv1a, respectively [8,9]. These three resi-
dues seem to be necessary for the biological activity of agele-
nin. More careful examination of the structures shows that
the overall structure of x-ACTX-Hv2a is diﬀerent from those
of agelenin and x-ACTX-Hv1a in terms of the topology of the
b-strands, whereas the latter two share a common feature. In
view of these structural features and the fact that the C-termi-
nal hydrophobic tail of x-ACTX-Hv2a is indispensable for its
activity, the mode of action of agelenin would resemble that of
x-ACTX-Hv1a rather than of x-ACTX-Hv2a. The channel
subtypes targeted by these peptides and the binding sites on
insect calcium channels have not been determined. The heter-
ologous expression for electrophysiological studies might facil-
itate the characterization of insect calcium channels and
understanding the mechanism of inhibition by these peptides.
In conclusion, we have determined the three-dimensional
structure of agelenin by NMR spectroscopy. Biological assays
showed that agelenin and its chimeric analogue, which have
Fig. 4. The eﬀects of wild-type agelenin (A) and chimeric analogue (B)
on rabbit Cav2.1 calcium channel recombinantly expressed in HEK
cells. Time-course of peak barium current amplitudes induced by 30-
ms depolarization to 0 mV from a holding potential of 80 mV.
Agelenin, the chimeric analogue and x-Aga-IVA were applied as
indicated by horizontal bars. After washout of x-Aga-IVA, tetanic
stimulation (B, 30 stimuli of 5-ms depolarization to 120 mV at 50 Hz)
was applied. Insets show the current traces recorded at times indicated
by the corresponding letters.
Fig. 5. The pharmacophore on the molecular surfaces of agelenin and
x-ACTX-Hv1a. The critical residues for toxin function (Pro10, Asn27
and Arg35) are labeled on the molecular surface of x-ACTX-Hv1a
[8,9]. Three residues (Phe9, Ser28 and Arg35) in agelenin are located in
similar positions in the pharmacophore of x-ACTX-Hv1a.
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insects but inactive on mammalian calcium channels. It can
now be concluded that the structure of the disulﬁde core re-
gion, in addition to the C-terminal hydrophobic tail which is
essential for activity in the case of x-Aga-IVA, is recognized
precisely by mammalian Cav2.1 calcium channels and that
the disulﬁde core region determines the species speciﬁcity. As
for insecticidal toxic activity, there are at least two diﬀerent
modes of action: x-ACTX-Hv1a inhibits insect calcium chan-
nels without the C-terminal tail, while x-ACTX-Hv2a requires
its C-terminal tail to exhibit the channel inhibition activity.
The structural similarity between agelenin and x-ACTX-
Hv1a suggests that agelenin inhibits insect calcium channels
in a similar manner to x-ACTX-Hv1a. We hypothesize that
Phe9, Ser28 and Arg33 in agelenin, corresponding to Pro10,
Asn27 and Arg35 in x-ACTX-Hv1a, respectively, are impor-
tant for insect calcium channel blocking activity. It should
be noted that the three side chains of agelenin are not well-con-
verged compared to the backbone fold, thus their orientations
would change upon binding to the channels. Also it is sug-
gested that the structures of the channels themselves slightly
change to accommodate the complex formation. Recently
Yu et al. have revealed that KcsA channel requires minor con-
formational changes in the extracellular loops to interact with
an antagonist charybdotoxin [29]. The activities of agelenin
analogues (F9A, S28A and R33A) towards insect calcium
channels and the structure of agalenin in complex with the tar-
get channel would give more insight into the mechanism by
which agelenin and similar insecticidal toxins inhibit calcium
channels. Our study also will shed light on the development
of new insecticides targeting calcium channels.
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